164 related articles for article (PubMed ID: 3450453)
1. Investigation of the criteria for assessing the outcome of treatment in acromegaly.
Lindholm J; Giwercman B; Giwercman A; Astrup J; Bjerre P; Skakkebaek NE
Clin Endocrinol (Oxf); 1987 Nov; 27(5):553-62. PubMed ID: 3450453
[TBL] [Abstract][Full Text] [Related]
2. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
3. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
[TBL] [Abstract][Full Text] [Related]
4. Somatomedin-C in active and successfully treated acromegaly.
Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
[TBL] [Abstract][Full Text] [Related]
6. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
[TBL] [Abstract][Full Text] [Related]
7. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
[TBL] [Abstract][Full Text] [Related]
8. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion.
Barkan AL; Beitins IZ; Kelch RP
J Clin Endocrinol Metab; 1988 Jul; 67(1):69-73. PubMed ID: 2897974
[TBL] [Abstract][Full Text] [Related]
9. Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery.
Edén S; Bengtsson BA; Albertsson-Wikland K; Elfversson J; Lindstedt G; Lundberg PA; Petruson B; Rosberg S
Acta Endocrinol (Copenh); 1989 Jan; 120(1):113-20. PubMed ID: 2492135
[TBL] [Abstract][Full Text] [Related]
10. Factors determining the long-term outcome of surgery for acromegaly.
Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
[TBL] [Abstract][Full Text] [Related]
11. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
12. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between clinical and endocrinological features following transsphenoidal surgery of acromegaly. With special reference to somatomedin-C level].
Osawa M; Kobayashi S; Takemae T; Nakagawa F
Neurol Med Chir (Tokyo); 1988 Mar; 28(3):254-8. PubMed ID: 2457827
[No Abstract] [Full Text] [Related]
14. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly.
de la Piedra C; Larrañaga J; Castro N; Horcajada C; Rapado A; Herrera Pombo JL; Carbó E
Calcif Tissue Int; 1988 Jul; 43(1):44-5. PubMed ID: 3145120
[TBL] [Abstract][Full Text] [Related]
15. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly.
Barreca A; Ciccarelli E; Minuto F; Bruzzi P; Giordano G; Camanni F
Acta Endocrinol (Copenh); 1989 May; 120(5):629-35. PubMed ID: 2728807
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?
Valdemarsson S; Ljunggren S; Cervin A; Svensson C; Isaksson A; Nordström CH; Siesjö P
Scand J Clin Lab Invest; 2001; 61(6):459-70. PubMed ID: 11681536
[TBL] [Abstract][Full Text] [Related]
19. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery?
van den Berg G; van Dulken H; Frölich M; Meinders AE; Roelfsema F
Clin Endocrinol (Oxf); 1998 Jul; 49(1):45-51. PubMed ID: 9797846
[TBL] [Abstract][Full Text] [Related]
20. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
